🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the safety and blood pressure lowe...
Status
Completed
Location
National Research Institute
Start Date
2007-02-27
Trial ID
NCT00422461
Treatments Being Tested
The primary objective of the study is to estimate the effects of different ...
Status
Completed
Location
Pfizer Clinical Research Unit
Start Date
2014-07
Trial ID
NCT02319148
Treatments Being Tested
The investigators propose that once daily administration of PF-00489791, a ...
Status
Completed
Location
Stanford Hospital and Outpatient Center
Start Date
2010-08-04
Trial ID
NCT01090492
Treatments Being Tested
Pregabalin is an alpha-2 delta ligand approved for the treatment of neuropa...
Status
Completed
Location
North Alabama RadioPharmacy
Start Date
2008-04-09
Trial ID
NCT00599638
Treatments Being Tested
PF-00489791 is an inhibitor of phosphodiesterase type 5. Our hypothesis is ...
Status
Completed
Location
Saadat Ansari Internal Medicine
Start Date
2010-12
Trial ID
NCT01200394
Treatments Being Tested
Study will assess PF-00489791 efficacy and safety in Pulmonary Arterial Hyp...
Status
Terminated
Location
Pulmonary Associates, PA
Start Date
2009-04
Trial ID
NCT00853112
Treatments Being Tested